» Articles » PMID: 1456559

Two-year Incidence of Tuberculosis in Cohorts of HIV-infected and Uninfected Urban Rwandan Women

Overview
Specialty Pulmonary Medicine
Date 1992 Dec 1
PMID 1456559
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the prevalence of Mycobacterium tuberculosis infection and the incidence of tuberculosis in HIV-infected and uninfected urban Rwandan women, 460 HIV-positive and 998 HIV-negative childbearing women were recruited from pediatric and prenatal care clinics and were enrolled in a prospective study in 1988 and followed for 2 yr. Tuberculin testing was administered 12 to 18 months after enrollment. Fifty-three percent of HIV-negative women had positive tuberculin tests (induration > or = 10 mm), with higher rates among older women and among women who had received BCG vaccine. Only 21% of HIV-positive women had positive tuberculin tests, with no relationship to BCG vaccine. Follow-up was available for 93% of subjects. Tuberculosis was diagnosed in 20 HIV-positive women and in two HIV-negative women. Features associated with an increased risk of tuberculosis among HIV-positive women included: age > or = 30, body mass index in the lowest quartile, low income, erythrocyte sedimentation rate > 75, positive tuberculin test, and chronic cough, chronic fever, and weight loss. Among Rwandan women who are infected with HIV, approximately half of those who are infected with M. tuberculosis do not have positive tuberculin tests. The rate ratio for development of tuberculosis among HIV-positive women was 22 (95% CI, 5 to 92). New algorithms are needed to improve the early detection of tuberculosis among HIV-positive patients in Africa.

Citing Articles

Trends of tuberculosis case detection, mortality and co-infection with HIV in Ghana: A retrospective cohort study.

Osei E, Oppong S, Der J PLoS One. 2020; 15(6):e0234878.

PMID: 32579568 PMC: 7313972. DOI: 10.1371/journal.pone.0234878.


The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control.

Osei E, Der J, Owusu R, Kofie P, Axame W BMC Infect Dis. 2017; 17(1):504.

PMID: 28724359 PMC: 5517831. DOI: 10.1186/s12879-017-2598-z.


Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.

Van-Dunem J, Rodrigues L, Alencar L, Militao-Albuquerque M, Ximenes R Biomed Res Int. 2015; 2015:275029.

PMID: 26221585 PMC: 4499653. DOI: 10.1155/2015/275029.


Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Murray C, Ortblad K, Guinovart C, Lim S, Wolock T, Roberts D Lancet. 2014; 384(9947):1005-70.

PMID: 25059949 PMC: 4202387. DOI: 10.1016/S0140-6736(14)60844-8.


Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.

Chkhartishvili N, Kempker R, Dvali N, Abashidze L, Sharavdze L, Gabunia P BMC Infect Dis. 2013; 13:513.

PMID: 24176032 PMC: 3817813. DOI: 10.1186/1471-2334-13-513.